1. Home
  2. >Research
  3. >Individuals With Pms2 Pathogenic Variants Are At Average Risk Of Cancer Before Age 60
Skip to main content
Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

Alexandre BolzeMarch 19, 2025Published Research

Ready to see the whole picture?

Connect with our team to discover how Helix can transform your approach to genomic medicine.

Connect with us
Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60 | Helix